HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Propylene glycol review

This article was originally published in The Rose Sheet

Executive Summary

Propylene glycol was found safe for use in cosmetic products in concentrations up to 50% by the Cosmetic Ingredient Review Expert Panel, CTFA says in comments to the Center for the Evaluation of Risks to Human Reproduction. In Jan. 10 submission, CTFA includes copy of 1994 CIR report and notes outcome of CERHR safety review is of interest to the Cosmetic, Toiletry and Fragrance industry. CERHR will review developmental and reproductive safety of propylene glycol and ethylene glycol at meeting in Alexandria, Va. Feb. 11-13. Arch Chemicals and American Chemistry Council also submitted comments. Draft reports on the ingredients were published in December (1"The Rose Sheet" Dec. 16, 2002, p. 9)...
Advertisement

Related Content

Propylene Glycol Dermal Absorption Data Included In CERHR Draft Report
Propylene Glycol Dermal Absorption Data Included In CERHR Draft Report
Advertisement
UsernamePublicRestriction

Register

RS010958

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel